- Home
- WF vs ITCI Comparison
WF vs ITCI Comparison
Compare WF & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WF
- ITCI
- Stock Information
- Founded
- WF 1899
- ITCI 2002
- Country
- WF South Korea
- ITCI United States
- Employees
- WF N/A
- ITCI N/A
- Industry
- WF Commercial Banks
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- WF Finance
- ITCI Health Care
- Exchange
- WF Nasdaq
- ITCI Nasdaq
- Market Cap
- WF 7.8B
- ITCI 8.7B
- IPO Year
- WF N/A
- ITCI N/A
- Fundamental
- Price
- WF $32.05
- ITCI $126.89
- Analyst Decision
- WF
- ITCI Buy
- Analyst Count
- WF 0
- ITCI 13
- Target Price
- WF N/A
- ITCI $100.31
- AVG Volume (30 Days)
- WF 60.4K
- ITCI 2.9M
- Earning Date
- WF 11-14-2024
- ITCI 02-20-2025
- Dividend Yield
- WF 11.45%
- ITCI N/A
- EPS Growth
- WF N/A
- ITCI N/A
- EPS
- WF 2.64
- ITCI N/A
- Revenue
- WF $7,567,454,676.00
- ITCI $613,728,000.00
- Revenue This Year
- WF N/A
- ITCI $48.41
- Revenue Next Year
- WF $1.44
- ITCI $38.26
- P/E Ratio
- WF $4.01
- ITCI N/A
- Revenue Growth
- WF N/A
- ITCI 46.08
- 52 Week Low
- WF $27.60
- ITCI $62.78
- 52 Week High
- WF $38.05
- ITCI $128.00
- Technical
- Relative Strength Index (RSI)
- WF 45.51
- ITCI 87.18
- Support Level
- WF $31.03
- ITCI $80.83
- Resistance Level
- WF $31.50
- ITCI $128.00
- Average True Range (ATR)
- WF 0.48
- ITCI 2.57
- MACD
- WF 0.15
- ITCI 4.45
- Stochastic Oscillator
- WF 76.87
- ITCI 97.65
About WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holdings company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. Its operating segments include Banking, Credit card, capital, Investment banking, and others.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.